| D00136 |
Haloperidol (JP16/USP/INN); Haldol (TN) |
(P) Enzyme: CYP2D6 / Target: DRD2 / CYP inhibition: CYP2D6 |
| D00184 |
Ciclosporin (JP16); Cyclosporine (USP); Gengraf (TN); Neoral (TN); Restasis (TN); Sandimmune (TN) |
(P) unclassified |
| D00236 |
Atovaquone (JAN/USP/INN); Mepron (TN) |
(P) unclassified |
| D00252 |
Carbamazepine (JP16/USP/INN); Equetro (TN); Tegretol (TN) |
(P) unclassified |
| D00298 |
Digoxin (JP16/USP); Lanoxicaps (TN); Lanoxin (TN) |
(P) unclassified |
| D00426 |
Risperidone (JP16/USAN/INN); Risperdal (TN) |
(P) Enzyme: CYP2D6 / Target: DRD2 / CYP inhibition: CYP2D6 |
| D00479 |
Prochlorperazine maleate (JP16/USP); Compazine (TN) |
(P) Target: DRD2 |
| D00502 |
Pergolide mesilate (JAN); Pergolide mesylate (USP); Permax (TN) |
(P) Enzyme: CYP2D6 / Target: DRD2 / CYP inhibition: CYP2D6 |
| D00503 |
Perphenazine (JP16/USP/INN); Trilafon (TN) |
(P) Enzyme: CYP2D6 / Target: DRD2 / CYP inhibition: CYP2D6 |
| D00538 |
Zonisamide (JAN/USAN/INN); Excegran (TN) |
(P) unclassified |
| D00559 |
Pramipexole hydrochloride hydrate (JAN); Pramipexole hydrochloride (USAN); Mirapex (TN) |
(P) Target: DRD2 |
| D00560 |
Pimozide (JP16/USP/INN); Orap (TN) |
(P) Enzyme: CYP2D6 / Target: DRD2 / CYP inhibition: CYP2D6 |
| D00603 |
Timolol maleate (JP16/USP); Blocadren (TN); Istalol (TN); Timoptic (TN) |
(P) Enzyme: CYP2D6 / CYP inhibition: CYP2D6 |
| D00661 |
Cevimeline hydrochloride hydrate (JAN); Cevimeline hydrochloride (USAN); Evoxac (TN); Saligren (TN) |
(P) Enzyme: CYP2D6 / CYP inhibition: CYP2D6 |
| D00780 |
Bromocriptine mesilate (JP16); Bromocriptine mesylate (USP); Parlodel (TN) |
(P) Target: DRD2 |
| D00784 |
Ropinirole hydrochloride (JAN/USAN); Requip (TN) |
(P) Target: DRD2 |
| D00785 |
Selegiline hydrochloride (JAN/USP); Eldepryl (TN) |
(P) Enzyme: CYP2D6 / CYP inhibition: CYP2D6 |
| D00789 |
Chlorpromazine hydrochloride (JP16/USP); Sonazine (TN) |
(P) Enzyme: CYP2D6 / Target: DRD2 / CYP inhibition: CYP2D6 |
| D00793 |
Fluphenazine decanoate (JAN/USP); Prolixin decanoate (TN) |
(P) Enzyme: CYP2D6 / Target: DRD2 / CYP inhibition: CYP2D6 |
| D00809 |
Amitriptyline hydrochloride (JP16/USP); Elavil (TN) |
(P) Enzyme: CYP2D6 / CYP inhibition: CYP2D6 |
| D00848 |
Dextromethorphan hydrobromide hydrate (JP16); Dextromethorphan hydrobromide (USP); Benylin DM (TN) |
(P) Enzyme: CYP2D6 / CYP inhibition: CYP2D6 |
| D00987 |
Cabergoline (JAN/USAN/INN); Cabaser (TN); Dostinex (TN) |
(P) Target: DRD2 |
| D01051 |
Spiperone (JAN/USAN); Spiropitan (TN) |
(P) Target: DRD2 |
| D01101 |
Bromperidol (JAN/USAN/INN); Impromen (TN) |
(P) Target: DRD2 |
| D01164 |
Aripiprazole (JAN/USAN/INN); Abilify (TN) |
(P) Enzyme: CYP2D6 / Target: DRD2 / CYP inhibition: CYP2D6 |
| D01226 |
Sulpiride (JP16/USAN/INN); Dogmatyl (TN) |
(P) Target: DRD2 |
| D01240 |
Deslanoside (JP16/USP/INN); Cedilanid-d (TN) |
(P) unclassified |
| D01321 |
Zotepine (JAN/INN); Setous (TN) |
(P) Target: DRD2 |
| D01448 |
Trifluoperazine maleate (JAN); Trifluoperazine (TN) |
(P) Target: DRD2 |
| D01449 |
Carpipramine maleate (JAN); Defekton (TN) |
(P) unclassified |
| D01451 |
Scopolamine butylbromide (JP16); Butylscopolamine bromide; Buscopan (TN) |
(P) unclassified |
| D01482 |
Pipamperone hydrochloride (JAN) |
(P) Target: DRD2 |
| D01485 |
Propericiazine (JAN); Periciazine; Neuleptil (TN) |
(P) Target: DRD2 |
| D01520 |
Levomepromazine hydrochloride (JAN/USAN); Nozinan (TN) |
(P) Enzyme: CYP2D6 / Target: DRD2 / CYP inhibition: CYP2D6 |
| D01522 |
Tiapride hydrochloride (JP16); Gramalil (TN) |
(P) Target: DRD2 |
| D01548 |
Mosapramine hydrochloride (JAN); Cremin (TN) |
(P) Target: DRD2 |
| D01898 |
Haloperidol decanoate (JAN/USAN); Halomonth (TN) |
(P) Enzyme: CYP2D6 / Target: DRD2 / CYP inhibition: CYP2D6 |
| D02004 |
Apomorphine hydrochloride hydrate (JAN); Apomorphine hydrochloride (USP); Apokyn (TN); Ixense (TN); Uprima (TN) |
(P) Target: DRD2 |
| D02022 |
Prochlorperazine mesilate (JAN); Prochlorperazine dimethanesulfonate; Novamin (TN) |
(P) Target: DRD2 |
| D02035 |
Timiperone (JAN); Tolopelon (TN) |
(P) Target: DRD2 |
| D02037 |
Perphenazine maleate (JP16); PZC (TN) |
(P) Enzyme: CYP2D6 / Target: DRD2 / CYP inhibition: CYP2D6 |
| D02106 |
Arsenic trioxide (JP16/USAN); Trisenox (TN) |
(P) unclassified |
| D02163 |
Fluphenazine maleate (JAN); Flumezin (TN) |
(P) Target: DRD2 |
| D02248 |
Levomepromazine maleate (JP16/USAN); Hirnamin (TN) |
(P) Enzyme: CYP2D6 / Target: DRD2 / CYP inhibition: CYP2D6 |
| D02371 |
Clocapramine hydrochloride hydrate (JP16); Clofekton (TN) |
(P) Target: DRD2 |
| D02372 |
Perospirone hydrochloride hydrate (JAN); Lullan (TN) |
(P) Target: DRD2 |
| D02472 |
Atovaquone - proguanil hydrochloride mixt; Malarone (TN) |
(P) unclassified |
| D02574 |
Atomoxetine hydrochloride (JAN/USAN); Tomoxetine hydrochloride; Strattera (TN) |
(P) Enzyme: CYP2D6 / CYP inhibition: CYP2D6 |
| D02587 |
Metildigoxin (JP16); Lanirapid (TN) |
(P) unclassified |
| D02615 |
Chlorpromazine hydrochloride - promethazine hydrochloride - phenobarbital mixt; Vegetamin (TN) |
(P) unclassified |
| D02713 |
Carpipramine hydrochloride hydrate (JAN); Carpipramine dihydrochloride; Defekton (TN) |
(P) unclassified |
| D04038 |
Perphenazine fendizoate (JAN); PZC (TN) |
(P) Enzyme: CYP2D6 / Target: DRD2 / CYP inhibition: CYP2D6 |
| D04340 |
Dextromethorphan hydrobromide - potassium cresolsulfonate mixt; Medicon (TN) |
(P) Enzyme: CYP2D6 / CYP inhibition: CYP2D6 |
| D04965 |
Perphenazine hydrochloride; Perphenazine dihydrochloride; PZC intramuscular injection (TN) |
(P) Enzyme: CYP2D6 / Target: DRD2 / CYP inhibition: CYP2D6 |
| D05768 |
Rotigotine (JAN/USAN/INN); Neupro (TN) |
(P) Target: DRD2 |
| D07505 |
Latanoprost - timolol maleate mixt; Xalacom (TN) |
(P) unclassified |
| D08493 |
Dorzolamide hydrochloride - timolol maleate mixt; Cosopt (TN) |
(P) unclassified |
| D08575 |
Tetrabenazine (JAN/INN); Nitoman (TN); Xenazine (TN) |
(P) unclassified |
| D08923 |
Fesoterodine fumarate (JAN/USP); Toviaz (TN) |
(P) unclassified |
| D09535 |
Mirabegron (USAN/JAN); Myrbetriq (TN) |
(P) unclassified |
| D09815 |
Travoprost - timolol maleate mixt; Duotrav (TN) |
(P) unclassified |
